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groups.
RESULTS 922 patients with ULMCA disease were ﬁnally enrolled for
the analyses: 465 were treated with DES implantation and 457 with
CABG. During the median follow-up of 7.1 years (interquartile range
5.3 to 8.2 years), no difference was found between PCI and CABG in
the occurrence of death (adjusted hazard ratio [HR]: 0.791; 95% con-
ﬁdence interval [CI]: 0.516 to 1.212; p¼0.282) and the composite end
point of cardiac death, MI and stroke (adjusted HR: 0.825; 95% CI:
0.576 to 1.182; p¼0.294). Rates of major adverse cardiac and cere-
brovascular events were signiﬁcantly higher in the PCI group
(adjusted HR: 1.394; 95% CI: 1.070 to 1.817; p¼0.014), in large part
because of the signiﬁcantly higher rate of repeat revascular-
ization(adjusted HR: 2.368; 95% CI: 1.653 to 3.392; p < 0.001). PCI was
correlated with lower occurrence of stroke (adjusted HR: 0.348; 95%
CI: 0.171 to 0.707; p ¼ 0.004).
CONCLUSIONS During a median follow-up of 7.1 years (IQR 5.3 to 8.2
years), there was still no difference in rate of death between PCI with
DES implantation and CABG in ULMCA lesions in this single-center
experience. CABG group was observed to have signiﬁcantly lower
rates of repeat revascularization but higher stroke rates compared
with PCI.
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Recanalization of coronary chronic total occlusion and its effects on
myocardial perfusion and long term outcome
Jingjing Wang, Luyue Gai, Qi Wang, Xue Zhai, Longtao Guan
Department of Cardiology, Chinese PLA General Hospital
OBJECTIVES The recanalization of the coronary chronic total occlu-
sion (CTO) is also not equal to the improved left ventricular function.
The present study will analyze what factors are contributing to suc-
cessful recanalization, the long term clinical outcomes and the effects
on myocardial salvage.
METHODS The patients who underwent coronary angiography (CAG)
from 2008 to 2013 were consecutively enrolled. The patients were
divided into 3 groups, the total occlusion and stenosis groups (group 1);
total occlusion myocardial perfusion group (group 2); CTO PCI
group (group 3). In the group 1 comparison was made between total
occlusion and high grade stenosis and the patients were followed for
the major adverse cardiovascular events. In the group 2 patients were
divided into total occlusion and stenosis. The SPECT summed rest
score, CAG indices (Syntax score, total MPG and MPGArea), echo-
cardiography indices (LVED and EF) were calculated. In the group 3,
559 CTO patients were divided into successful and unsuccessful
recanalization. The MPG, Bridge Point, Retrograde MPG, LVED and EF
were calculated.
RESULTS In the group 1, 253 total occlusion and 629 stenosis were
included. No difference in clinical characters was found between
total occlusion and stenosis except Syntax score. The MACE was
signiﬁcantly higher in total occlusion than in stenosis (P<0.05). No
difference in MACE among PCI, CABG and medicine treatments. In
the group 2 there were 111 patients who underwent SPECT and
CAG, of them 41 had total occlusion and 70 had stenosis. The total
occlusion had signiﬁcantly larger SRS, higher SYNTAX score,
reduced total MPG and MPGArea, enlarged LVED and reduced EF
(P<0.05). Stepwise multivariate analysis showed that the SRS were
independently correlated with EF, total occlusion and sex. In the
group 3, 559 CTO attempted PCI. The success rate was 67%.
Stepwise multivariate analysis showed age, unfavorite CTO and
higher J-score predicted unsuccessful recanalization. After suc-
cessful PCI there were 175 MPG2-3 and 99 MPG0-1. Low MPG
accounted for 36% and had low Bridge Point, low Retrograde MPG
and increased LVED (P<0.05). There were 190 Bridge Point 0-1 and
369 Bridge Point 2-3. Low Bridge Point accounted for 34%. After
PSmatch we found that low Bridge Point were correlated with
complex CTO, high J-score, Retrograde MPG, low EF and enlarged
LVED (P<0.05)
CONCLUSIONS Medication and CABG have similar clinical outcome
irrespective of CTO or stenosis. But CTO PCI may have poor clinical
outcome in comparison with stenosis. In CTO PCI the artery integrity
damage is more than stenosis. The myocardial perfusion and left
ventricular function are poor in the CTO patients. MPG, total MPG,
Bridge Point, EF and LVED are useful predictors of myocardial re-
covery after successful recanalization. Age, complex CTO and J-Score
are 3 main anatomic factors affecting recanalization. MPG and Bridge
Point help predict viability after recanalization.GW26-e1571
Efﬁcacy and safety of 6-month dual antiplatelet therapy for more than
75 year old patients having BUMA implantation
Jieyun Liu, Zhenjun Wang, Wen Yang, Chenchen Li, Lei Qin
The Kaifeng central Hospital
OBJECTIVES 12-month dual antiplatelet therapy (DAPT) is recom-
mended after implantation of drug-eluting stents (DESs) in patients
with coronary heart disease. BUMA is a new drug-eluting stent with
two different functional coating layers, and More than 75 year old
patients have more complications like bleeding and gastrointestinal
intolerance. The time is not clear for elderly patients with BUMA
implantation.
METHODS We reviewed the data of 242 consecutive more than 75 year
old patients who had BUMA implantation four years ago and
completed 6-month DAPT. They were divided into two groups
randomly: 6-month and 12-month DAPT groups. The efﬁcacy (a
composite incidence of cardiac death, myocardial infarction and
target vessel revascularization) and safety (incidences of bleeding,
gastrointestinal trouble and drug discontinuation) were compared
with two groups.
RESULTS 242 patients included in the analysis, 118 were 6-month
DAPT group, 124were 12-month DAPT group. The mean follow-up
duration was 241.8 months after BUMA implantation. The age,
history of hypertension and stroke, BMI, SBP, DBP, high-density
lipoprotein-cholesterol (HDL-C), triglycerides (TG), fasting blood
glucose (FBG), estimated glomerular ﬁltration rate (eGFR), at baseline
did not differ signiﬁcantly between the two groups. The rates of multi-
vessel lesions, prior MI, hemoglobin A1C (HbA1c) and low-density
lipoprotein cholesterol were no difference signiﬁcantly in two groups.
There was no signiﬁcant difference in the overall composite incidence
of cardiac death, myocardial infarction and target vessel revasculari-
zation in two groups at one years after PCI. The rates of bleeding
(especially minor bleeding), gastrointestinal trouble, drug discontin-
uation and any blood transfusion were markedly lower in the 6-month
DAPT group than 12-month DAPT group (2.54%vs4.84%;4.24%
vs6.45%;5.09%vs8.06%;0.85%vs2.42%, P<0.05).
CONCLUSIONS 6-month DAPT may be more preferable to more than
75 year old patients who have undergone BUMA implantation,
because of it’s efﬁcacy and safety.GW26-e4527
The importance of serial measurement of platelet aggregation in long-term
dual antiplatelet therapy following drug eluting stent implantation
Fang Chen
Department of Cardiology, Beijing An Zhen Hospital, Capital Medical
University and Beijing Institute of Heart Lung and Blood Vessel
Disease, Beijing
OBJECTIVES Dual antiplatelet therapy (DAPT) and the response to
clopidogrel are two pivotal issues impacting on the use of drug-
eluting stents (DESs). Consequently, we analyzed the combined in-
ﬂuence of these factors to evaluate their long term effect in patients
undergoing DES implantation.
METHODS Platelet aggregation was serially measured by light trans-
mission aggregometry in all eligible patients during the course of
treatment with DAPT, and the mean platelet aggregation level of each
participant was calculated. Based on the duration of DAPT and the
mean platelet aggregation level, all the enrolled patients were then
divided into four groups. The primary endpoint was a composite of
all-cause death, nonfatal myocardial infarction (MI), stent thrombosis,
unexpected repeat revascularization, and stroke.
RESULTS We analyzed 1,245 suitable patients in this study. These
were divided into group A (12 month DAPT & low platelet aggregation
level) with 204 subjects, group B (>12 month DAPT & high platelet
aggregation level) with 419 subjects, group C (12 month DAPT & high
platelet aggregation level) with 289 subjects, and group D (>12 month
DAPT & low platelet aggregation level) with 333 subjects. Compared
with all other groups, group D was associated with a decreased inci-
dence of primary endpoints [HR 0.485, 95%CI (0.25–0.96); P ¼ 0.038].
When the Cox proportional hazards model was further tested with D
group as the reference category within the same group, groups B and C
were associated with increased incidence of primary endpoints [HR
2.26, 95%CI (1.10–4.68); P ¼ 0.0273] and [HR 2.31, 95%CI (1.03–5.18);
P ¼ 0.0413]. Their respective multivariate Cox proportional hazards
regressions conﬁrmed these trends.
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level is of importance in long term use of DAPT; extended DAPT
beyond one year should be personalized in patients implanted
with a DES.
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Intravascular ultrasound-guided wiring technique for stumpless chronic
total occlusion
Mingjie Pang, Hong Zhang
The First People’s Hospital of Yunnan Province
OBJECTIVES To evaluate safety and efﬁcacy of IVUS -guided
wiring technique for stumpless chronic total occlusion (CTO)
lesions.
METHODS 40 Patients with blunt and vague stump (stumpless) CTO
lesions while could not determine the wire progress orientation, were
selected in this study. The IVUS catheter was introduced into the side
branch and it was withdrawn from the side branch to ﬁnd the entry
point of the occlusion, then guiding the progress of guiding wire.
Procedural success rate, operation time, contrastor dosage and com-
plications (such as emergent operation, fatal myocardial infarction
and death) were evaluated during hospitalization and 6 months
follow-up.
RESULTS A total of 42 CTO lesions were enrolled between March
2013 and October 2014. The left anterior descending artery was the
most common target-lesion location [27 lesions (64%)]. CTO lesions
were successfully reopened in 31 lesions (74%). The entry point
could not be identiﬁed in two; Guiding wire progress in the false
lumen of subintimal in 10 and full guide-wire passage was impos-
sible in 9; TIMI 3 ﬂow could not be achieved even after stenting in
2. Guiding wire manipulation- related vessel injury was detected by
IVUS in 16 lesions (coronary hematoma in 8, coronary peroration in 2).
There was not serious complication such as fatal myocardial
infarction, emergent operation and death during or after the
procedures.
CONCLUSIONS The IVUS-guided wiring penetration technique is
useful and safe for the recanalization of stumpless CTO lesions.
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Short-term clinical outcomes for bifurcation treatment using a provisional
T-stenting and double proximal optimization technique with Absorb
bioresorbable scaffolds.
Alexey Biryukov, Roman Ivanchenko, Mikhail Kaputin
Pavlov First Saint Petersburg State Medical University
OBJECTIVES Bioresorbable scaffolds (BVS) are being increasingly
used for bifurcation lesions. The aim of this study to evaluate the
feasibility and short-term safety of the Absorb BVS in a bifurcation
lesions using a provisional T-stenting with double proximal optimi-
zation technique (POT).
METHODS A total of 22 bifurcation lesions with in 22 patients (586
age, 14 males) were treated in our center with at least one BVS be-
tween September 2014 and February 2015. There were 7 (31.8%) cases
with true bifurcation (Medina 1.1.1 and 1.0.1), 9 (40.9%) cases with a
classiﬁcation of (0.1.0) and 6 (27.3%) cases with a classiﬁcation of
(1.1.0). Most of bifurcation lesions were treated in the anterior
descending artery (15 cases), 5 - in the circumﬂex, and in 2 cases - in
the right coronary artery. Main branch pre-dilatation were performed
in 22 (100%) cases. A provision 1 scaffold strategy was employed in 21
patients. And in 1 patient using T-stenting technique. POT with small
length balloon (8.0-10.0 mm) was performed in each procedure twice.
After BVS implantation in main branch, and as ﬁnal technique after
side branch dilatation. Kissing balloons were not used. Balloon
catheters not more then 2.0 mm diameter were used for side branch
dilatation. In order to prevent damage of the BVS struts wile
removing «jailed wire» only coronary wires with hydrophilic coating
were used.
RESULTS Lesion success occurred in all cases with no signiﬁcant re-
sidual stenosis at the bifurcation. TIMI 3 ﬂow was noted after proce-
dure in both the main and side branch in all cases. There were no cases
of periprocedural myocardial infarction. At 30 days follow-up there
was no any major cardiac adverse events.
CONCLUSIONS Bifurcation lesions can be safety treated with BVS
with good short-term outcomes when a provision T-stenting tech-
nique with double POT is planed.GW26-e3838
The long-term effect of immediate and delayed PCI for ST-segment
elevation acute myocardial infarction on cardiac function and myocardial
infarct size
Tongku Liu, Hongyan Ma, Shujie Wu, Ming Gu, Yanbin Zhu, Lihua Xu,
Feng Sun
The Cardiovascular Center, Afﬁliated Hospital, Beihua University, Jilin,
China
OBJECTIVES To evaluate the long-term effect of immediate and
delayed PCI for patients with ST-segment elevation acute myocardial
infarction (STEMI) on cardiac function and myocardial infarct size.
METHODS A total of 563 patients with STEMI were treated in our
hospital form December 2003 to December 2010. Among them 157
patients were treated by immediate PCI (immediate PCI group) who
received PCI in 12 hours from onset of the chest pain, 124 patients
were treated by delayed PCI (delayed PCI group) who received PCI
from 13 hours to three weeks after onset of the chest pain, 131 patients
were treated by the intravenous thrombolytic therapy (intravenous
thrombolytic group) who did not receive PCI, and 151 patients were
only treated by medical therapy (medical therapy group). All patients
were followed lasting for 4527 months (24-88 months). The major
adverse cardiac events (MACE) deﬁned as cardiac death, nonfatal
recurrent myocardial infarction, heart failure and recurrent unstable
angina, were recorded during follow-up. The cardiac structure
and function were detected by echocardiography. The myocardial
infarct size was estimated by the QRS point system in the last time of
follow-up.
RESULTS Average period of the hospital stay (9.23.9 days) in
delayed PCI group was signiﬁcantly shorter than those (18.75.1days)
in thrombolytic group and (19.64.9 days) medical therapy group
(P<0.05), but was similar to those (8.85.7 days) in immediate PCI
group. The rate of the cumulative MACE (30.7%) in delayed PCI and
(22.9%) in immediate PCI were signiﬁcantly less than those (39.8%) in
thrombolytic group and (42.0%) in medical therapy group (P<0.05).
Compared with thrombolytic and medical therapy group, the inci-
dence of heart failure in delayed PCI and in immediate PCI group was
less (P<0.05) during follow-up period. The LVEF(62.76.8%) in im-
mediate PCI and (55.86.3%) in delayed PCI group was signiﬁcantly
higher than that (50.46.8%) in thrombolytic group and (46.67.0%)
in medical therapy group (P<0.05) during the last time of follow-up.
The LVDd (47.64.5 mm) in immediate PCI and (49.95.1 mm) in
delayed PCI group was signiﬁcantly less than that (54.56.3 mm) in
thrombolytic and (58.44.9 mm) in medical therapy group. Decrease
of QRS score-estimated MI size by initial and follow-up electrocar-
diograms in immediate PCI and in delayed PCI was greater than that in
medical group and similar to that in thrombolytic group.
CONCLUSIONS The immediate PCI and delayed PCI for patients with
STEMI may shorten in-hospital stay, decrease the rate of MACE during
follow-up, decrease infarct size and improve left ventricular function.
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Effect of high sensitivity troponin T of patients in pressure wire dealing
with critical lesion during coronary artery intervention
Shenghu He
Department of Cardiovascular Medicine, Northen Jiangsu People’s
Hospital, Yangzhou, Jiangsu, Medical College of Yangzhou University,
Yangzhou, Jiangs
OBJECTIVES To investigate effect of high sensitivity troponin
T(hs-cTnT) and pressure wire in the coronary artery interventional
therapy in treating critical lesion.
METHODS We recruited 86 patients with clinical diagnosis of coro-
nary heart disease who had at least one segmental stenosis degree
between 40%w70% in one major coronary artery on coronary angi-
ography. All of the patients received preoperative hs-cTnT and FFR.
They were divided into PCI group and control group. PCI group: Pa-
tients with FFR<0.75 were treated with PCI, and they were further
divided into hs-cTnT rise group (0.034 ng / mL) and hs-cTnT normal
group (<0.034 ng / mL). The control group: Patients with FFR0.75
received conservative drug therapy. The number of lesions and stent
implantation of patients in PCI group were observed. The incidence
rates of typical angina, nonfatal myocardial infarction, cardiac death
and target vessel revascularization and other major adverse cardiac
events (MACE) during hospitalization and follow’up among three
groups were compared.
